Bremer Trust National Association’s Emergent Biosolutions EBS Stock Holding History

Bremer Trust National Association’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$17K	Buy	+281	New	+$18.1K	﹤0.01%	587

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bremer Trust National Association's EBS Position: Q4 2018 in Review

Bremer Trust National Association opened a new position in Emergent Biosolutions (EBS) in Q4 2018: 281 shares worth $17K. The stake represents ﹤0.01% of the portfolio and ranks #587 among its holdings.

297 funds tracked by Wall St. Rank hold EBS as of Q4 2018.

Bremer Trust National Association held 281 shares of Emergent Biosolutions worth $17K as of Q4 2018.
Emergent Biosolutions was a new Bremer Trust National Association position in Q4 2018.
Emergent Biosolutions made up ﹤0.01% of Bremer Trust National Association's portfolio in Q4 2018, its #587 holding.
297 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2018.

Based on Bremer Trust National Association's 13F filing for Q4 2018, filed 11 Feb 2019.